Fragmin is a drug manufactured by American pharmaceutical giant Pfizer, the world's largest research based pharmaceutical company and the developers of such famous drugs as Viagra and Lipitor to name just a few.
Fragmin is the brand name version of the drug dalteparin sodium, and is a solution which is administered via injection. It belongs to a class of medicines collectively referred to as low molecular weight heparins or antithrombotics and works by helping prevent the formation of blood clots. It does this by thinning the blood and is used to treat patients suffering from the condition venous thromboembolism. This is perhaps better known as a treatment for deep vein thrombosis and pulmonary embolism.
Fragmin, in a 2003 study involving patients suffering from either malignant or acute venous thromboembolism was shown to be superior to the effects of warfarin, a much older drug used for the same purpose. Furthermore, research has shown that Fragmin does not accumulate even in the event that a patient's kidney function is compromised.
For these reasons, since Pfizer introduced Fragmin, it has gained a lot of traction in the pharmacy world as a first line treatment with better effects and less side effects than options like warfarin.
Fragmin is licensed for preventing blood clots in the conditions described above and providing you do not have any allergies or other issues that would prevent it being used for treating you such as fluid mixed with blood around the heart and lungs or suffer from conditions such as haemophilia or liver failure.
Dosing recommendations for children are based on the clinician's experience with limited clinical data on its use in children or adolescents.
Fragmin is typically administered by a doctor or nurse or else a patient is shown how they can administer the drug themselves. It is usually given as a single daily injection subcutaneously (below the skin but not into a vein or muscle). Always refer to the product literature.